{
    "title": "TGaceAllStories",
    "link": "http://example.com/interleaved_feed.json",
    "description": "This is a randomly ordered feed of the most recent entries from TGaceAllStories, skipping any feeds with errors.",
    "lastBuildDate": "2025-09-29T06:35:38.013730",
    "items": [
        {
            "title": "Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating",
            "link": "https://www.marketwatch.com/story/morgan-stanley-expects-novo-nordisk-alzheimer-trial-to-fail-as-it-slashes-rating-98a9eeee?mod=mw_rss_topstories",
            "description": "Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, ...",
            "pubDate": "2025-09-29T10:36:00",
            "image_url": "https://images.mktw.net/im-86179513"
        },
        {
            "title": "How the Trump administration is boosting stock buybacks",
            "link": "https://www.marketwatch.com/story/the-trump-effect-on-share-buybacks-theres-more-of-them-a8d93235?mod=mw_rss_topstories",
            "description": "Gavekal Research predicts more stock repurchases are coming, representing an additional tailwind for the current bull market.",
            "pubDate": "2025-09-29T10:22:00",
            "image_url": "https://images.mktw.net/im-79494160"
        },
        {
            "title": "Months after cancer drug trial, Merus agrees to be bought at 41% premium",
            "link": "https://www.marketwatch.com/story/months-after-cancer-drug-trial-merus-agrees-to-be-bought-at-41-premium-d7e87829?mod=mw_rss_topstories",
            "description": "Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.",
            "pubDate": "2025-09-29T10:34:00",
            "image_url": "https://images.mktw.net/im-34081553"
        },
        {
            "title": "‘He’s the breadwinner’: Does my husband take Social Security at 66 — or wait to get $800 extra at 70?",
            "link": "https://www.marketwatch.com/story/hes-the-breadwinner-does-my-husband-take-social-security-at-66-or-wait-to-get-800-extra-at-70-33b0ed85?mod=mw_rss_topstories",
            "description": "“My husband jokes that he will never be able to retire because we do not own a home.”",
            "pubDate": "2025-09-29T10:25:00",
            "image_url": "https://images.mktw.net/im-40443151"
        },
        {
            "title": "‘I thought she was honest’: My ex-wife hid stocks during our divorce. Can I sue her?",
            "link": "https://www.marketwatch.com/story/i-thought-she-was-honest-my-ex-wife-hid-her-stocks-during-our-divorce-can-i-sue-her-e75cab43?mod=mw_rss_topstories",
            "description": "“I have contacted her about it, but she refuses to answer my calls.”",
            "pubDate": "2025-09-29T11:23:00",
            "image_url": "https://images.mktw.net/im-37270843"
        },
        {
            "title": "Morgan Stanley downgrades Wells Fargo, sees limited upside ahead",
            "link": "https://www.cnbc.com/2025/09/29/morgan-stanley-downgrades-wells-fargo-sees-limited-upside-ahead.html",
            "description": "Don't expect much more upside for Wells Fargo, according to Morgan Stanley.",
            "pubDate": "2025-09-29T11:27:21",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png"
        },
        {
            "title": "BYD bids Warren Buffett's Berkshire an unfazed farewell: Selling is 'normal'",
            "link": "https://www.cnbc.com/2025/09/27/byd-warren-buffett-berkshire-hathaway.html",
            "description": "As it confirmed Berkshire has sold the last of its shares, the Chinese EV maker thanked Buffett and Munger for their 17-year investment.",
            "pubDate": "2025-09-28T03:40:32",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Want to beat the market for the long term? JPMorgan says bet on termites",
            "link": "https://www.cnbc.com/2025/09/28/want-to-beat-the-market-for-the-long-term-jpmorgan-says-bet-on-termites.html",
            "description": "Rollins could gain ground as the firm deepens its push into the \"resilient,\" multibillion-dollar pest control market in the U.S. and abroad, per J.P. ...",
            "pubDate": "2025-09-28T12:43:25",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Top Wall Street analysts favor these 3 stocks for their robust growth outlook",
            "link": "https://www.cnbc.com/2025/09/28/top-wall-street-analysts-favor-these-3-stocks-for-robust-growth.html",
            "description": "TipRanks' ranking service highlights three stocks, including Nvidia and CrowdStrike, that are favored by Wall Street.",
            "pubDate": "2025-09-28T12:48:35",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Trump is wielding the power of the state to back critical mineral companies. These are the possible next targets",
            "link": "https://www.cnbc.com/2025/09/28/mp-materials-lithium-americas-lac-rare-earth-trump-stake.html",
            "description": "The Pentagon deal with MP Materials could provide a blueprint to protect U.S miners against market manipulation by China, executives and analysts say.",
            "pubDate": "2025-09-28T12:45:51",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "Datavault AI (DVLT) Rockets on $150 Million Scilex Cash Infusion: The Deal That’s Got Traders Buzzing",
            "link": "https://ragingbull.com/editorial/datavault-ai-dvlt-rockets-on-150-million-scilex-cash-infusion-the-deal-thats-got-traders-buzzing/",
            "description": "Listen up, folks—markets don’t hand out fireworks like this every day, but when they do, you better pay attention. As of this writing, early in the tr...",
            "pubDate": "2025-09-26T14:39:33",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "bioAffinity Technologies Stock Explodes 80%+ in Pre-Market on Fresh Lung Cancer Detection Wins",
            "link": "https://ragingbull.com/editorial/bioaffinity-technologies-stock-explodes-80-in-pre-market-on-fresh-lung-cancer-detection-wins/",
            "description": "Listen up, folks—markets are a wild ride, and right now, one tiny biotech name is stealing the show with a pre-market pop that could make your head sp...",
            "pubDate": "2025-09-26T14:40:57",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        },
        {
            "title": "MRM Stock Explodes on Game-Changing Partnership with Sam Altman’s World: Inside the Pre-Market Surge",
            "link": "https://ragingbull.com/editorial/mrm-stock-explodes-on-game-changing-partnership-with-sam-altmans-world-inside-the-pre-market-surge/",
            "description": "Folks, if you’re scanning the markets this morning, you’ve got to be seeing this one lighting up the screens like a Fourth of July fireworks show. MED...",
            "pubDate": "2025-09-26T14:37:14",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Safe & Green Holdings (SGBX) Surges on Long-Awaited Litigation Settlement – What’s Driving the Buzz in Modular Construction?",
            "link": "https://ragingbull.com/editorial/safe-green-holdings-sgbx-surges-on-long-awaited-litigation-settlement-whats-driving-the-buzz-in-modular-construction/",
            "description": "Listen up, folks – if you’re glued to the markets this morning, you’ve probably spotted Safe & Green Holdings Corp. (NASDAQ: SGBX) lighting up the boa...",
            "pubDate": "2025-09-25T14:47:16",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        },
        {
            "title": "Plus Therapeutics (PSTV) Rockets 40% on Major Insurance Win for Cancer Detection Tool – Here’s Why Traders Are Buzzing",
            "link": "https://ragingbull.com/editorial/plus-therapeutics-pstv-rockets-40-on-major-insurance-win-for-cancer-detection-tool-heres-why-traders-are-buzzing/",
            "description": "Listen up, folks – if you’re glued to the market this morning, you’ve probably spotted that wild mover lighting up your screen: Plus Therapeutics, tic...",
            "pubDate": "2025-09-25T14:48:19",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        }
    ]
}